Cure SMA
Non-Profit & Charitable Organizations · Illinois, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
925 Busse Rd, Elk Grove Village, Illinoi...Phone Number
(800) 886-1762Website
www.curesma.orgRevenue
$13.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
2
1
1
About Cure SMA
Cure SMA is dedicated to the treatment and cure of SMA. Since 1984, Cure SMA has grown to be the largest network of individuals, families, clinicians, and research scientists working together to advance SMA research, support the full SMA community, and educate public and professional communities about SMA. The organization has directed and invested in comprehensive research that has shaped the scientific community's understanding of SMA, led to breakthroughs in treatment and care, and provides individuals and families the support they need today.Explore more
Cure SMA Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cure SMA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Cure SMA has new funding data
Check out if Cure SMA is spiking on competitors!
Click to see if Cure SMA had a recent Job posting/layoffs
Check if Cure SMA has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Cure SMA
Earning: See what the market has to say on Cure SMA recently announced quarterly report
Cure SMA, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Cure SMA launches new products
Recommended Actions
Reach out to Masked Content who joined Cure SMA as Masked Content
Find 2 more new buyers
Compare Similar Companies to Cure SMA
Compare insights from companies similar to Cure SMA, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cure SMA is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Cure SMA is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Cure SMA.
Cure SMA Tech Stack
A closer look at the technologies used by Cure SMA
See more technologies
Most Recent Scoops
New Hire
Executive Move
Debora Pellicano has recently joined the organization as Chief Financial Officer.
Executive Moves, New Hire
Person-Based
Person-Based
Person-Based
Cure SMA News & Media
Federal Law Brings Hope to Individuals and Families Living with SMA, Expands Access and Research
WASHINGTON, Feb. 3, 2026 /PRNewswire/ -- Cure SMA today announced that key research and legislative priorities championed by the spinal muscular atrophy (SMA) community have been approved by Congress and signed into law by the President as part of the Consolidated Appropriations Act of...Cure SMA Welcomes Broad FDA Approval of Itvisma™ for Spinal Muscular Atrophy, Reinforces Commitment to Patient Access and Support
SCHAUMBURG, Ill., Nov. 26, 2025 /PRNewswire/ -- Cure SMA, the leading nonprofit organization dedicated to supporting those impacted by spinal muscular atrophy (SMA), welcomes the FDA approval of Itvisma™ (onasemnogene abeparvovec-brve) by Novartis for adults and children 2 years of age...Scholar Rock to Present Comprehensive Update at 2025 Annual Cure SMA Research and Clinical Care Meeting, Including Positive Results from Pivotal Phase 3 SAPPHIRE Trial
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, announced today that it will present data from its Phase 3 SAPPHIRE clinical trial (NCT05156320) in an oral presentation at Cure SMA’s Annual SMA Research & Clinical Care Meeting being held June 25-27, 2025, in Anaheim, California.Cytokinetics and Cure SMA Renew Partnership to Advance Education and Awareness of SMA
SOUTH SAN FRANCISCO, Calif. and ELK GROVE VILLAGE, Ill., Aug. 19, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) and Cure SMA today announced the renewal of their partnership to increase education, awareness, public policy and fundraising for spinal muscular atrophy (SMA). Cytokinetics will be a National Gold Sponsor in support of several key Cure SMA initiatives across the United States.
Read more news
Top Non-Profit & Charitable Organizations Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cure SMA
Sign Up For FreeTo access detailed company insights
Cure SMA is dedicated to the treatment and cure of SMA. Since 1984, Cure SMA has grown to be the largest network of individuals, families, clinicians, and research scientists working together to advance SMA research, support the full SMA community, and educate public and professional communities about SMA. The organization has directed and invested... Read More
